TrialInternational journal of chronic obstructive pulmonary disease2021

Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study.

William A Fahy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.